Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 201,130,720
  • Shares Outstanding, K 1,750,942
  • Annual Sales, $ 43,075 M
  • Annual Income, $ 7,071 M
  • 60-Month Beta 0.73
  • Price/Sales 4.60
  • Price/Cash Flow 15.51
  • Price/Book 5.56
Trade ABT with:

Options Overview Details

View History
  • Implied Volatility 25.28% ( -2.38%)
  • Historical Volatility 31.97%
  • IV Percentile 70%
  • IV Rank 49.56%
  • IV High 34.29% on 03/08/22
  • IV Low 16.42% on 09/01/21
  • Put/Call Vol Ratio 0.98
  • Today's Volume 11,590
  • Volume Avg (30-Day) 8,216
  • Put/Call OI Ratio 0.55
  • Today's Open Interest 235,643
  • Open Int (30-Day) 254,309

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 1.11
  • Number of Estimates 8
  • High Estimate 1.33
  • Low Estimate 1.01
  • Prior Year 1.17
  • Growth Rate Est. (year over year) -5.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
104.63 +11.53%
on 05/12/22
118.74 -1.73%
on 04/28/22
-0.03 (-0.03%)
since 04/27/22
3-Month
104.63 +11.53%
on 05/12/22
124.36 -6.17%
on 04/08/22
-5.72 (-4.67%)
since 02/25/22
52-Week
104.63 +11.53%
on 05/12/22
142.60 -18.17%
on 12/27/21
+1.00 (+0.86%)
since 05/27/21

Most Recent Stories

More News
Bubs baby formula from Australia gets FDA import approval

The Biden administration has employed an all-of-government approach to bolstering infant formula supplies until domestic manufacturing can return to normal.

ABT : 116.69 (+1.58%)
Abbott vs. Stryker: Which Medical Devices Stock is a Better Investment?

Given the increasing investments in R&D and technological integrations, and the rebounding demand for critical surgical procedures, the medical devices industry is well-positioned to grow. This should...

ABT : 116.69 (+1.58%)
SYK : 236.50 (+0.66%)
Diandra “Fu” Debrosse Zimmermann Becomes First Black Woman Ever Appointed to Lead a Multidistrict Litigation with Co-Lead Counsel Selection in Baby Formula MDL

Diandra “Fu” Debrosse Zimmermann made legal history today, becoming the first black woman ever appointed plaintiffs’ co-lead counsel in a multidistrict litigation. Debrosse Zimmermann was appointed...

ABT : 116.69 (+1.58%)
ESLOY vs. ABT: Which Stock Should Value Investors Buy Now?

ESLOY vs. ABT: Which Stock Is the Better Value Option?

ESLOY : 80.5700 (+1.60%)
ABT : 116.69 (+1.58%)
FDA authorizes more baby formula imports as air cargo pipeline grows

The latest baby formula developments include relaxed regulations to support more imports, an air cargo pipeline and congressional scrutiny.

ABT : 116.69 (+1.58%)
Abbott (ABT) to Commence Limited Release of EleCare Soon

Abbott's (ABT) release of limited quantities of EleCare branded specialty formulas to be free of charge to children in need.

ABT : 116.69 (+1.58%)
PDCO : 31.87 (+1.34%)
AMN : 95.63 (+2.01%)
VEEV : 172.00 (+3.92%)
Is Applied UV Stock a Good Stock to Own in 2022?

Despite reporting an increase in revenue in its last reported quarter, Applied UV’s (AUVI) EPS and revenue came in lower than analysts’ estimates. However, analysts expect the company’s EPS to improve...

ABT : 116.69 (+1.58%)
AUVI : 0.9780 (+0.48%)
FONR : 16.23 (+0.50%)
SHWGY : 4.1900 (-1.18%)
Abbott (ABT) Transcatheter Valve Devices' Study Data Favorable

Abbott's (ABT) study data presented at EuroPCR 2022 reinforces the company's commitment to offering structural heart solutions, supported by clinical evidence that exceeds existing standards of care.

ABT : 116.69 (+1.58%)
UNH : 507.11 (+0.97%)
ALKS : 30.54 (+4.02%)
MEDP : 147.37 (+8.73%)
What Is the Answer to the Baby Formula Shortage?

All of the headlines in Food&Bev this week

BZY00 : 628.71s (-0.41%)
BVY00 : 654.59s (-0.71%)
BWY00 : 592.66s (+0.03%)
BXY00 : 853.28s (-0.04%)
BYY00 : 704.63s (-1.22%)
ABT : 116.69 (+1.58%)
BYND : 28.63 (+9.40%)
OTLY : 4.19 (+8.83%)
TAP : 55.15 (+1.14%)
BUD : 56.65 (+0.30%)
Abbott (ABT) Down 8.9% Since Last Earnings Report: Can It Rebound?

Abbott (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ABT : 116.69 (+1.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 118.69
2nd Resistance Point 117.81
1st Resistance Point 117.25
Last Price 116.69
1st Support Level 115.80
2nd Support Level 114.92
3rd Support Level 114.36

See More

52-Week High 142.60
Fibonacci 61.8% 128.10
Fibonacci 50% 123.62
Fibonacci 38.2% 119.13
Last Price 116.69
52-Week Low 104.63

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar